Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marks Biotech is a private Indian dental and healthcare products company focused on dental implantology, regenerative dental products, digital dentistry, and navigation-enabled surgical workflows. The company primarily operates as a distributor, importer, and solutions provider rather than a therapeutics developer, supplying dental implants, prosthetic products, bone regenerative materials, surgical accessories, and related equipment. Its offering also includes robotic and dynamic navigation systems, photogrammetry-enabled workflows, clinical support, training, and market-entry or regulatory support for partners entering India and South Asia. Marks Biotech appears to serve dental clinicians and hospitals across India from its Chennai base, with a network spanning multiple cities. Based on currently available public information, it is best characterized as a commercial-stage healthcare device and dental solutions company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marks Biotech.